DrugPatentWatch Database Preview
ESOMEPRAZOLE MAGNESIUM Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Esomeprazole Magnesium, and what generic alternatives are available?
The generic ingredient in ESOMEPRAZOLE MAGNESIUM is esomeprazole magnesium. There are seventy drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the esomeprazole magnesium profile page.
Summary for ESOMEPRAZOLE MAGNESIUM
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 13 |
| Suppliers / Packagers: | 63 |
| Bulk Api Vendors: | 71 |
| Clinical Trials: | 14 |
| Patent Applications: | 21 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ESOMEPRAZOLE MAGNESIUM |
| DailyMed Link: | ESOMEPRAZOLE MAGNESIUM at DailyMed |
Pharmacology for ESOMEPRAZOLE MAGNESIUM
| Drug Class | Proton Pump Inhibitor |
| Mechanism of Action | Proton Pump Inhibitors Cytochrome P450 2C19 Inhibitors |
Synonyms for ESOMEPRAZOLE MAGNESIUM
| 161973-10-0 |
| 1H-Benzimidazole, 5-methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-, magnesium salt, trihydrate |
| 217087-09-7 |
| 217087-10-0 |
| 382E335 |
| 5-methoxy-1H-1,3-benzimidazol-2-yl (4-methoxy-3,5-dimethyl-2-pyridinyl)methyl sulfoxide |
| 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole, magnesium salt (2:1) |
| 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole, magnesium salt (2:1), trihydrate |
| 95382-33-5 |
| A810316 |
| AB00698386-07 |
| AB2000267 |
| AC-402 |
| AC-4540 |
| AC1L2XM7 |
| AC1L2XMA |
| AC1NSJYQ |
| AKOS015896379 |
| AKOS015967196 |
| AKOS025311414 |
| AKOS025402081 |
| AN-11885 |
| AN-15879 |
| AN-34918 |
| azol-1-ide |
| CCG-100986 |
| CE0112 |
| CHEBI:94401 |
| CHEMBL1567328 |
| CPD004727568 |
| CS-1024 |
| CTK8E8954 |
| D05259 |
| Esomeprazole (Magnesium trihydrate) |
| Esomeprazole magnesium dihydrate |
| Esomeprazole magnesium trihydrate |
| ESOMEPRAZOLE Mg |
| Esomeprazole(magnesium) |
| FT-0625712 |
| FT-0657297 |
| H 168/68 magnesium |
| H199/18 |
| HE073137 |
| HE073437 |
| HE316079 |
| HMS2051H21 |
| HMS2235F19 |
| HMS2878H13 |
| HMS3372O13 |
| HMS3393H21 |
| HY-17022 |
| I06-1976 |
| IN2364 |
| J-014249 |
| KS-1054 |
| KWORUUGOSLYAGD-UHFFFAOYSA-N |
| LS-181810 |
| magnesium 5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide 6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imid |
| magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]benzimidazol-1-ide |
| magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-ide |
| magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-ide trihydrate |
| magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]benzimidazol-1-ide |
| magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide |
| magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide trihydrate |
| magnesium bis(5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide) |
| Magnesium, bis(5-methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl-kappaO)-1H-benzimidazolato-kappaN1)-, trihydrate, (T-4)- |
| magnesium;5-methoxy-2-[(R)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide;tri |
| magnesium(2+) bis(5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazol-1-ide) |
| MAGNESIUM(2+) ION 5-METHOXY-2-[(4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL)METHANESULFINYL]-1H-1,3-BENZODIAZOL-1-IDE 6-METHOXY-2-[(4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL)METHANESULFINYL]-1H-1,3-BENZODIAZOL-1-IDE |
| MAGNESIUM(2+) ION BIS(5-METHOXY-2-[(4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL)METHANESULFINYL]-1H-1,3-BENZODIAZOL-1-IDE) TRIHYDRATE |
| MFCD06798050 |
| MFCD07698573 |
| MLS001165732 |
| MLS001401413 |
| MolPort-005-940-841 |
| MolPort-016-633-260 |
| MRF-0000267 |
| N Bis (1H-Benzimidazole,5-methoxy-2-[(S)-[4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl]-) |
| NC00236 |
| Nexium |
| Omeprazole magnesium |
| omeprazole magnesium (10 mg) |
| Omeprazole magnesium (USAN) |
| Omeprazole magnesium [USAN:USP] |
| Omeprazole magnesium [USAN] |
| omeprazole magnesium, ep |
| omeprazole mg |
| Prilosec OTC (TN) |
| Q-100195 |
| RT-012496 |
| SAM001246538 |
| SC-72064 |
| SCHEMBL665194 |
| SCHEMBL722792 |
| SMR000469280 |
| SMR000550477 |
| ST24046692 |
| ST51053319 |
| STL455071 |
| UNII-426QFE7XLK |
| VEVZQDGATGBLIC-UHFFFAOYSA-N |
US Patents and Regulatory Information for ESOMEPRAZOLE MAGNESIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alkem Labs Ltd | ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED REL PELLETS;ORAL | 208333-001 | Oct 20, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Sun Pharm Inds Ltd | ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED REL PELLETS;ORAL | 209735-002 | Apr 30, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Hec Pharm Co Ltd | ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED REL PELLETS;ORAL | 207265-002 | May 18, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Aurobindo Pharma Ltd | ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED REL PELLETS;ORAL | 205606-002 | Apr 21, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
